[1]
N. J. Polotovich, “FEATURES OF ATRIAL FIBRILLATION DEVELOPMENT IN PATIENTS WITH THYROTOXICOSIS”, EJMMP, vol. 1, no. 1, pp. 71–76, Dec. 2021.